Management Forum Logo

Presented by
Management Forum

Post-Market Surveillance and Vigilance of Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Training Course

Learn the essential regulatory requirements for post-market surveillance (PMS), post-market clinical follow-up (PMCF), and vigilance of digital health technologies, ensuring product safety, compliance, and continued value creation throughout the product lifecycle

10-11 June 2026
+ 2-3 December 2026 »

from £649

Need help?  Enrol/reserve

Course overview

This intensive course provides a comprehensive overview of regulatory obligations, risk management, incident reporting, and corrective actions, together with practical tips to ensure that such products remain compliant and safe throughout their lifecycle.

Post-market surveillance (PMS), post-market clinical follow-up (PMCF), complaints, and vigilance handling are vital to ensure compliance of digital health technologies with or without the use of artificial intelligence. In this practical one-day course, you will learn the regulatory requirements needed for successful PMS, PMCF and vigilance of digital health technologies (DHTs). The intensive course will exemplify how proactive and reactive sources of information are essential in PMS procedures of such devices. Also, the course will highlight why developing a PMS plan and PMCF early in software development, will ensure that different sources of information can be targeted to enable a cost-effective product launch. Identifying the right post-market information will assure continued compliance and will trigger consumer shifting needs, enabling a total product life cycle development, and continous value creation in the post-market chain.

The program will be highly interactive, using real-life examples and state-of-the-art practices across different global jurisdictions. Practical insights will be provide, hands-on exercises, and case studies to guide you through the intricate decisions needed that affect your market access processes.

The course will cover:

  • Overview of PMS requirements for SaMD and MDSW in different global regulatory frameworks (e.g., EU MDR, USA FDA).
  • Understand Risk Management and PMS Planning: a PMS plan tailored for software products.
  • Monitoring and Data Collection: insights on the use of real-world data and user feedback to improve product safety and performance.
  • Incidence reporting and vigilance:
    • Identifying reportable events, incidents, and serious adverse events.
    • Regulatory requirements for vigilance reporting and timelines.
  • Corrective and Preventive Actions (CAPA)
  • Ensuring continuous product improvement through PMCF: changes to the benefit-risk profile and intended-use.

This course is part of our Vigilance training course collection; for information on the basics of PhV, consider taking a look at our beginner-friendly Pharmacovigilance training course.

Benefits of attending

  • Confirm the regulatory requirements for PMS for SaMD & MDSW, and how these are interpreted in ISO 13485, ISO 14971 and various guidance documents. 
  • Create a Post-market Surveillance procedure that is both proactive and reactive. 
  • Implement cost-effective and targeted PMCF using various techniques. 
  • Recognize when a complaint needs to be reported as an adverse event or incident for marked devices.

Who should attend?

This training is suitable for all professionals involved in the post-market surveillance and vigilance of software as a medical device and medical device software, including: 

  • Regulatory Professionals
  • Quality Managers
  • Clinical Affairs Specialists
  • Complaint Handling Specialists
  • Design and Development Professionals
  • EU Authorised Representatives

Enrol/reserve

This course will cover:

Overview of requirements

  • PMS requirements for SaMD and MDSW in different global regulatory frameworks (e.g., EU MDR, USA FDA).

Understand risk management and PMS planning

  • A PMS plan tailored for software products.

Monitoring and data collection

  • Insights on the use of real-world data and user feedback to improve product safety and performance

Incidence reporting and vigilance

  • Identifying reportable events, incidents, and serious adverse events
  • Regulatory requirements for vigilance reporting and timelines

Corrective and Preventive Actions (CAPA)

Ensuring continuous product improvement through PMCF

  • Changes to the benefit-risk profile and intended-use

Enrol/reserve

Catarina Carrao
BioSciPons

Catarina Carrão is the founder of BioSciPons, a life sciences research organisation specialising in health technologies clinical development, evaluation and assessment, with expertise in AI/ML-enabled technologies. She co-ordinates expert teams to bridge the gap between innovation and regulatory compliance, helping developers navigate complex requirements while meeting the expectations of Notified Bodies and the FDA.

Catarina's academic background includes a Marie-Curie Fellowship at Charité Berlin, and Postdoctoral Fellowship at Yale's University Cardiovascular Research Center. She is a Fellow of the American Heart Association (FAHA) since 2013, Delegate of the European Society of Cardiology (ESC), and Professional member of the Health Technology Assessment International (HTAi) organization. She is an expert for the European Commission HaDEA on clinical investigations and Digital Health Technologies, and for the European Innovation and Technology (EIT) Council Health Cluster.

She has presented at RAPS Euroconvergence, the ESC Digital & AI Summit, and DIA Europe on AI/ML medical device regulation, post-market monitoring, and reimbursement pathways. Her recent publications include book chapters and articles on machine learning best practices, AI trustworthiness, and EU MDR/IVDR clinical evaluation.

More details

NEW higher discounts for multiple bookings - bring your colleagues to make your training budget go further:

  • 30% off the 2nd delegate*
  • 40% off the 3rd delegate*
  • 50% off the 4th delegate*

Please contact us for pricing if you are interested in booking 5 or more delegates

10-11 June 2026

Live online

09:00-12:30 UK (London) (UTC+01)
10:00-13:30 Paris (UTC+02)
04:00-07:30 New York (UTC-04)
Course code 16303

  • GBP 649 749
  • EUR 909 1,049
  • USD 1,043 1,199

Until 06 May

View basket 

 
Not ready to book yet?

for 7 days, no obligation

2-3 December 2026

Live online

09:00-12:30 UK (London) (UTC+00)
10:00-13:30 Paris (UTC+01)
04:00-07:30 New York (UTC-05)
Course code 16596

  • GBP 649 749
  • EUR 909 1,049
  • USD 1,043 1,199

Until 28 Oct

View basket 

 
Not ready to book yet?

for 7 days, no obligation

* Early booking discounts may not be combined with other discounts or offers. As such, the discounts for 2nd/3rd/4th delegates are based on the full price; and apply only when booking multiple delegates on the same date.

Germany

  • PAUL HARTMANN AG

Spain

  • Werfen

Enrol/reserve

Run Post-Market Surveillance and Vigilance of Software as a Medical Device (SaMD) and Medical Device Software (MDSW) Live online for your team

1 day

Typical duration

Pricing from:

  • GBP 500
  • Per attendee, based on 10 attendees
  • Course tailored to your requirements
  • At your choice of location, or online

 

We can customise this course to your requirements and deliver it on an in-house basis for any number of your staff or colleagues.

Contact our in-house training experts Aleksandra Beer and Yesim Nurko to discuss your requirements:

Multiple colleagues? See above for details of our discounts for 2, 3, or 4 delegates. For more, talk to one of our training experts to discuss how to:

Run this course conveniently and cost-effectively in-house for your staff and colleagues

Aleksandra Beer

Aleksandra
BEER

Yesim Nurko

Yesim
NURKO

Yesim Nurko

Harry
ALTAMONT

+44 (0)20 7749 4749

inhouse@ipiacademy.com